Carclo PLC

Investor

For Investors

Carclo plc

Financial Reports

FY25 KPI scorecards

From operational discipline to sustainable growth, Carclo delivers validated precision at scale in Life Sciences and Aerospace.

ROS

10.1%

FY25

8.1%

2bps

ROCE

28.8%

FY25

24.4%

4.4bps

Net debt ratio

1.4

FY25

1.2x

0.2

Revenue £m

117.5

FY25

£121.2m

£3.7m

uEPS

0.9p

FY25

4.3p

3..4p

HY26 Summary

Portfolio reset complete: fewer, better programmes; safer & cleaner operational architecture. ROS achieved the target of 10% and similarly, ROCE hit the 25% target. Capital, capacity and talent prioritised to high-return lines. Net debt at 1.4 (FY25 1.2). Next: margin-led growth.

Technology

Validated precision at scale

End-to-end capability from design and tooling to automated, qualified production in-region

ROS 8.1%, tracking towards 10%

Trust

Assurance you can audit

Regulated quality, full traceability and disciplined execution across Life Sciences and Aerospace.

ROCE 24.4%, tracking towards 25%.

Transformation

Margin before volume

Portfolio simplified, capital and capacity focused on high-return lines

Net debt 1.2× (from 2.0× FY24).